Skip to content

Clinical trials

Phase 2 Head and Neck Neoplasms trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Phase: Phase 2 Country / region: Singapore Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20083
20152
20171
20181
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting3
Unknown status3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Centre, Singapore3
ALX Oncology Inc.2
AstraZeneca1
BeiGene1
Celgene1
Hoffmann-La Roche1
National University Hospital, Singapore1
Novartis Pharmaceuticals1
Taiho Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms12
Squamous Cell Carcinoma of Head and Neck3
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Renal Cell2
Melanoma2
Pancreatic Neoplasms2
Brain Neoplasms1
Breast Neoplasms1
Cholangiocarcinoma1
Colorectal Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.